Democratic Republic of Congo vs Laos: Pneumococcal conjugate second or third-dose vaccines (PCVc)

Democratic Republic of Congo
63.0%
in 2025
Laos
62.0%
in 2025
Democratic Republic of Congo rank
140th
Laos rank
142nd

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • Democratic Republic of Congo
  • Laos
020406080200820162025

How they compare

Democratic Republic of Congo currently reports 63.0% against 62.0% in Laos, a difference of 1.0%.

The two have swapped places 5 times across 18 shared years of data; in 2008 it was Laos ahead.

Democratic Republic of Congo ranks 140th and Laos ranks 142nd of 192 countries.

Democratic Republic of Congo has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Democratic Republic of Congo Laos Difference Ahead
2000s 0.0% 0.0% 0.0%
2010s 44.9% 42.9% 2.0% Democratic Republic of Congo
2020s 63.5% 62.3% 1.2% Democratic Republic of Congo

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Democratic Republic of Congo or Laos?
Democratic Republic of Congo, at 63.0% against 62.0% in Laos as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Democratic Republic of Congo and Laos?
1.0%, with Democratic Republic of Congo ahead.
How many years of comparable data are there for Democratic Republic of Congo and Laos?
18 years are reported by both, from 2008 to 2025.
How do Democratic Republic of Congo and Laos rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Democratic Republic of Congo ranks 140th and Laos ranks 142nd of 192 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Democratic Republic of Congo vs Laos: Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 August 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/congo-dem-rep/lao-pdr/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/congo-dem-rep/lao-pdr/">Democratic Republic of Congo vs Laos: Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
206 places, 3,705 data points, 2008–2025
Last refreshed